<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04951401</url>
  </required_header>
  <id_info>
    <org_study_id>soh-Med-21-06-06</org_study_id>
    <nct_id>NCT04951401</nct_id>
  </id_info>
  <brief_title>Pattern of Dyslipidemia Among Patients With Acute Coronary Syndrome at Sohag University Hospital</brief_title>
  <official_title>Pattern of Dyslipidemia Among Patients With Acute Coronary Syndrome at Sohag University Hospital</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sohag University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sohag University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study, I am aime to analyze lipid profile in patients with ACS who presents at sohag&#xD;
      university hospital, and its clinical and complications pattern.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Coronary artery disease (CAD) is the most important cause of death in men and women The great&#xD;
      majority of ACS patients have at least one major risk factor.&#xD;
&#xD;
      Acute Coronary Syndrome (ACS) is a major reason for Coronary Care Unit ( CCU )sohag&#xD;
      university hospital admission The risk of CAD was about 4 and 3 times higher in male and&#xD;
      female smokers than nonsmokers respectively (Baba S et. al ; 2006) Dyslipidemia has been&#xD;
      identified as one of most important modifiable risk factor for CAD . Treating dyslipidemia&#xD;
      has clear benefits in the primary and secondary prevention of coronary heart disease (CHD) in&#xD;
      both sexes . This study focused on dyslipidemia as a risk factor of acute coronary syndrome&#xD;
      (ACS).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 1, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>dyslipiemia in acute coronary syndrome</measure>
    <time_frame>one year</time_frame>
    <description>pattern of dyslipidemia among patients with acute coronary syndrome at sohag university hospital</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Acute Coronary Syndrome</condition>
  <arm_group>
    <arm_group_label>Normal &amp; abnormal lipid parameters value</arm_group_label>
    <description>parameters value among normal and abnormal lipid profile</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>lipid profile</intervention_name>
    <description>lipid profile</description>
    <arm_group_label>Normal &amp; abnormal lipid parameters value</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>ECG</intervention_name>
    <description>ECG</description>
    <arm_group_label>Normal &amp; abnormal lipid parameters value</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        about 100 adult patients will be included in this study aged above 18 years old diagnosed&#xD;
        acute coronary syndrome&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria::&#xD;
&#xD;
        clinical diagnosed Acute coronary syndromes&#xD;
&#xD;
        -&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  chronic coronary syndrome&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>esraa m abdelfatah, resident</last_name>
    <role>Principal Investigator</role>
    <affiliation>esraa m abdelfatah</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>esraa m abdelfatah, resident</last_name>
    <phone>01024352744</phone>
    <email>mesraa623@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>ali altaher, lecture</last_name>
    <phone>01003376529</phone>
  </overall_contact_backup>
  <reference>
    <citation>Graichen C, Tanner C. Diagnosis of Acute Coronary Syndrome. Am Fam Physician. 2018 Aug 1;98(3):Online.</citation>
    <PMID>30215890</PMID>
  </reference>
  <reference>
    <citation>Dali B. Clinical Profile, Dyslipidemia and ACS - a Correlation. JNMA J Nepal Med Assoc. 2014 Jul-Sep;52(195):907-13.</citation>
    <PMID>26982665</PMID>
  </reference>
  <results_reference>
    <citation>Ray KK, Ditmarsch M, Kallend D, Niesor EJ, Suchankova G, Upmanyu R, Anzures-Cabrera J, Lehnert V, Pauly-Evers M, Holme I, Štásek J, van Hessen MW, Jones P; dal-ACUTE Investigators. The effect of cholesteryl ester transfer protein inhibition on lipids, lipoproteins, and markers of HDL function after an acute coronary syndrome: the dal-ACUTE randomized trial. Eur Heart J. 2014 Jul 14;35(27):1792-800. doi: 10.1093/eurheartj/ehu105. Epub 2014 Mar 17.</citation>
    <PMID>24639426</PMID>
  </results_reference>
  <results_reference>
    <citation>Eisen A, Giugliano RP, Braunwald E. Updates on Acute Coronary Syndrome: A Review. JAMA Cardiol. 2016 Sep 1;1(6):718-30. doi: 10.1001/jamacardio.2016.2049. Review.</citation>
    <PMID>27438381</PMID>
  </results_reference>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 18, 2021</study_first_submitted>
  <study_first_submitted_qc>June 25, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 6, 2021</study_first_posted>
  <last_update_submitted>June 25, 2021</last_update_submitted>
  <last_update_submitted_qc>June 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sohag University</investigator_affiliation>
    <investigator_full_name>Esraa Mostafa Abdelfattah</investigator_full_name>
    <investigator_title>principal investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acute Coronary Syndrome</mesh_term>
    <mesh_term>Dyslipidemias</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>dyslipidemia at acute coronary syndrome</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

